Company Filing History:
Years Active: 1989
Title: Yuichi Hatada: Innovator in Blood Platelet Aggregation Inhibition
Introduction
Yuichi Hatada is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit blood platelet aggregation. His work is essential for advancing medical treatments and improving patient outcomes.
Latest Patents
Yuichi Hatada holds a patent for 3-Oxoalkylidene-2-azetidinone derivatives, specifically 2-Azetidione derivatives. These compounds are represented by a specific formula wherein various groups and atoms are defined, including hydrogen, halogen, lower alkyl groups, and more. The compounds are particularly useful as blood platelet aggregation inhibiting agents, showcasing their potential in therapeutic applications.
Career Highlights
Hatada is associated with Taisho Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His work at Taisho has allowed him to focus on innovative solutions that address critical health issues. His patent reflects his dedication to research and development in the medical field.
Collaborations
Yuichi Hatada has collaborated with esteemed colleagues such as Yutaka Kawashima and Masakazu Satoh. These collaborations have likely contributed to the success of his research and the development of his patented compounds.
Conclusion
Yuichi Hatada's contributions to the field of pharmaceuticals, particularly through his patent for blood platelet aggregation inhibitors, highlight his role as an innovator. His work continues to impact medical science and improve health outcomes for patients.